HYBIO PHARMACEUTIC financial statements, including revenue, expenses, profit, and loss
The total revenue of 300199 for the last quarter is 148.81 M CNY, and it's 494.70% higher compared to the previous quarter. The net income of Q1 24 is -14.10 M CNY.